Lipopolyplex potentiates anti-tumor immunity of mRNA-based vaccination

Dendritic cells and the control of immunity

Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,244 · see citing works

Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer

Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572 · see citing works

Neoantigens in cancer immunotherapy

Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783 · see citing works

Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8

Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., & Bauer, S. (2004) · Science · doi:10.1126/science.1093620 · Cited by 3,947 · see citing works

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., & Reis e Sousa, C. (2004) · Science · doi:10.1126/science.1093616 · Cited by 3,444 · see citing works

Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy

Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,771 · see citing works

A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells

Carreno, B. M., Magrini, V., Becker-Hapak, M., Kaabinejadian, S., Hundal, J., Petti, A. A., Ly, A., Lie, W.-R., Hildebrand, W. H., Mardis, E. R., et al. (2015) · Science · doi:10.1126/science.aaa3828 · Cited by 1,285 · see citing works

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing

Yadav, M., Jhunjhunwala, S., Phung, Q. T., Lupardus, P., Tanguay, J., Bumbaca, S., Franci, C., Cheung, T. K., Fritsche, J., Weinschenk, T., et al. (2014) · Nature · doi:10.1038/nature14001 · Cited by 1,186 · see citing works

CELL BIOLOGY OF ANTIGEN PROCESSING IN VITRO AND IN VIVO

Trombetta, E. S., & Mellman, I. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104538 · Cited by 1,173 · see citing works

gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma

Schwartzentruber, D. J., Lawson, D. H., Richards, J. M., Conry, R. M., Miller, D. M., Treisman, J. S., Gailani, F., Riley, L. B., Conlon, K. C., Pockaj, B. A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1012863 · Cited by 913 · see citing works

Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling

Koivusalo, M., Welch, C. M., Hayashi, H., Scott, C. C., Kim, M., Alexander, T. R., Touret, N., Hahn, K. M., & Grinstein, S. (2010) · The Journal of Cell Biology · doi:10.1083/jcb.200908086 · Cited by 878 · see citing works

Therapeutic vaccines for cancer: an overview of clinical trials

Melero, I., Gaudernack, G., Gerritsen, W. R., Huber, C., Parmiani, G., Scholl, S., Thatcher, N. J., Wagstaff, J., Zielinski, C. C., Faulkner, I., et al. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.111 · Cited by 773 · see citing works

Clinical use of dendritic cells for cancer therapy

Anguille, S., Smits, E., Lion, E., Tendeloo, V. F. V., & Berneman, Z. N. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70585-0 · Cited by 707 · see citing works

Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes

Shukla, S. A., Rooney, M. S., Rajasagi, M., Tiao, G., Dixon, P. M., Lawrence, M. S., Stevens, J. D., Lane, W. J., DellaGatta, J. L., Steelman, S., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3344 · Cited by 654 · see citing works

Injectable, spontaneously assembling, inorganic scaffolds modulate immune cells in vivo and increase vaccine efficacy

Kim, J., Li, A. W., Choi, Y., Lewin, S. A., Verbeke, C. S., Dranoff, G., & Mooney, D. J. (2014) · Nature Biotechnology · doi:10.1038/nbt.3071 · Cited by 541 · see citing works

Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells

Van Tendeloo, V. F. I., Ponsaerts, P., Lardon, F., Nijs, G., Lenjou, M., Van Broeckhoven, C., Van Bockstaele, D. R., & Berneman, Z. N. (2001) · Blood · doi:10.1182/blood.v98.1.49 · Cited by 468 · see citing works

B16 as a Mouse Model for Human Melanoma

Overwijk, W. W., & Restifo, N. P. (2000) · Current Protocols in Immunology · doi:10.1002/0471142735.im2001s39 · Cited by 437 · see citing works

M1 and M2 Macrophages: The Chicken and the Egg of Immunity

Mills, C. D., & Ley, K. F. (2014) · Journal of Innate Immunity · doi:10.1159/000364945 · Cited by 401 · see citing works

Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients

Weide, B., Pascolo, S., Scheel, B., Derhovanessian, E., Pflugfelder, A., Eigentler, T. K., Pawelec, G., Hoerr, I., Rammensee, H.-G., & Garbe, C. (2009) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181a00068 · Cited by 378 · see citing works

A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design

Avci, F. Y., Li, X., Tsuji, M., & Kasper, D. L. (2011) · Nature Medicine · doi:10.1038/nm.2535 · Cited by 365 · see citing works

Messenger RNA-based Vaccines With Dual Activity Induce Balanced TLR-7 Dependent Adaptive Immune Responses and Provide Antitumor Activity

Fotin-Mleczek, M., Duchardt, K. M., Lorenz, C., Pfeiffer, R., Ojkić-Zrna, S., Probst, J., & Kallen, K.-J. (2011) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181f7dbe8 · Cited by 335 · see citing works

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

Kreiter, S., Selmi, A., Diken, M., Koslowski, M., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0699 · Cited by 309 · see citing works

From the RNA world to the clinic

Sullenger, B. A., & Nair, S. (2016) · Science · doi:10.1126/science.aad8709 · Cited by 274 · see citing works

Results of the First Phase I/II Clinical Vaccination Trial With Direct Injection of mRNA

Weide, B., Carralot, J.-P., Reese, A., Scheel, B., Eigentler, T. K., Hoerr, I., Rammensee, H.-G., Garbe, C., & Pascolo, S. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31815ce501 · Cited by 261 · see citing works

RNA-Based Vaccines in Cancer Immunotherapy

McNamara, M. A., Nair, S. K., & Holl, E. K. (2015) · Journal of Immunology Research · doi:10.1155/2015/794528 · Cited by 223 · see citing works

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Lint, S. V., Goyvaerts, C., Maenhout, S. K., Goethals, L., Disy, A., Benteyn, D., Pen, J. J., Bonehill, A., Heirman, C., Breckpot, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2957 · Cited by 210 · see citing works

A phase IB study on intravenous synthetic mRNA electroporated dendritic cell immunotherapy in pretreated advanced melanoma patients

Wilgenhof, S., Nuffel, A. M. T. V., Benteyn, D., Corthals, J., Aerts, C., Heirman, C., Riet, I. V., Bonehill, A., Thielemans, K., & Neyns, B. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt245 · Cited by 204 · see citing works

Toll‐like receptor‐dependent activation of several human blood cell types by protamine‐condensed mRNA

Scheel, B., Teufel, R., Probst, J., Carralot, J., Geginat, J., Radsak, M. P., Jarrossay, D., Wagner, H., Jung, G., Rammensee, H., et al. (2005) · European Journal of Immunology · doi:10.1002/eji.200425656 · Cited by 198 · see citing works

TNF-α-dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection

Trevejo, J., Marino, M. W., Philpott, N. J., Josien, R., Richards, E. C., Elkon, K. B., & Falck-Pedersen, E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211423598 · Cited by 198 · see citing works

Enhanced Dendritic Cell Maturation by TNF-α or Cytidine-Phosphate-Guanosine DNA Drives T Cell Activation In Vitro and Therapeutic Anti-Tumor Immune Responses In Vivo

Brunner, C., Seiderer, J., Schlamp, A., Bidlingmaier, M., Eigler, A., Haimerl, W., Lehr, H., Krieg, A. Μ., Hartmann, G., & Endres, S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.11.6278 · Cited by 192 · see citing works

Systemic delivery of modified mRNA encoding herpes simplex virus 1 thymidine kinase for targeted cancer gene therapy.

Wang, Y.-H., Su, H.-H., Yang, Y., Hu, Y.-X., Zhang, L., Blancafort, P., & Huang, L. (2013) · Molecular Therapy · doi:10.1038/mt.2012.250 · Cited by 189 · see citing works

mRNA-based dendritic cell vaccines

Benteyn, D., Heirman, C., Bonehill, A., Thielemans, K., & Breckpot, K. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2014.957684 · Cited by 181 · see citing works

IL-12p70–producing patient DC vaccine elicits Tc1-polarized immunity

Carreno, B. M., Becker‐Hapak, M., Huang, A. C. C., Chan, M., Alyasiry, A., Lie, W., Aft, R., Cornelius, L. A., Trinkaus, K. M., & Linette, G. P. (2013) · Journal of Clinical Investigation · doi:10.1172/jci68395 · Cited by 164 · see citing works

Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses

De Beuckelaer, A., Pollard, C., Van Lint, S., Roose, K., Van Hoecke, L., Naessens, T., Udhayakumar, V. K., Smet, M., Sanders, N., Lienenklaus, S., et al. (2016) · Molecular Therapy · doi:10.1038/mt.2016.161 · Cited by 122 · see citing works

Particle-mediated intravenous delivery of antigen mRNA results in strong antigen-specific T-cell responses despite the induction of type I interferon

Broos, K., Van der Jeught, K., Puttemans, J., Goyvaerts, C., Heirman, C., Dewitte, H., Verbeke, R., Lentacker, I., Thielemans, K., & Breckpot, K. (2016) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2016.38 · Cited by 121 · see citing works

A development that may evolve into a revolution in medicine: mRNA as the basis for novel, nucleotide-based vaccines and drugs

Kallen, K., & Theß, A. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613508729 · Cited by 120 · see citing works

Evading innate immunity in nonviral mRNA delivery: don't shoot the messenger.

Devoldere, J., Dewitte, H., De Smedt, S. C., & Remaut, K. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.07.009 · Cited by 112 · see citing works

Porous Silicon Microparticle Potentiates Anti-Tumor Immunity by Enhancing Cross-Presentation and Inducing Type I Interferon Response

Xia, X., Mai, J., Xu, R., Perez, J. E. T., Guevara, M. L., Shen, Q., Mu, C., Tung, H.-Y., Corry, D. B., Evans, S. E., et al. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.04.009 · Cited by 103 · see citing works

Characterization of the ribonuclease activity on the skin surface

Probst, J., Brechtel, S., Scheel, B., Hoerr, I., Jung, G., Rammensee, H.-G., & Pascolo, S. (2006) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-4-4 · Cited by 84 · see citing works

Poly(β-amino ester) Nanoparticle Delivery of TP53 Has Activity against Small Cell Lung Cancer In Vitro and In Vivo

Kamat, C. D., Shmueli, R. B., Connis, N., Rudin, C. M., Green, J. J., & Hann, C. L. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0956 · Cited by 45 · see citing works

Lentiviral Protein Transfer Vectors Are an Efficient Vaccine Platform and Induce a Strong Antigen-Specific Cytotoxic T Cell Response

Uhlig, K. M., Schülke, S., Scheuplein, V., Malczyk, A. H., Reusch, J., Kugelmann, S., Muth, A., Koch, V., Hutzler, S., Bodmer, B. S., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00844-15 · Cited by 27 · see citing works

Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System

Hayashi, Y., Hatakeyama, H., Kajimoto, K., Hyodo, M., Akita, H., & Harashima, H. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00184 · Cited by 14 · see citing works

Lipid nanoparticles for mRNA delivery

Hou, X., Zaks, T., Langer, R., & Dong, Y. (2021) · Nature Reviews Materials · doi:10.1038/s41578-021-00358-0 · Cited by 4,076 · see citing works

mRNA vaccine for cancer immunotherapy

Miao, L., Zhang, Y., & Huang, L. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01335-5 · Cited by 947 · see citing works

Lipids and Lipid Derivatives for RNA Delivery

Zhang, Y., Sun, C., Wang, C., Jankovic, K. E., & Dong, Y. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00244 · Cited by 638 · see citing works

Advances in COVID-19 mRNA vaccine development

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00950-y · Cited by 601 · see citing works

Therapeutic cancer vaccines: Advancements, challenges, and prospects

Fan, T., Zhang, M., Yang, J., Zhu, Z., Cao, W., & Dong, C. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01674-3 · Cited by 597 · see citing works

Opportunities and Challenges in the Delivery of mRNA-Based Vaccines

Wadhwa, A., Aljabbari, A., Lokras, A., Foged, C., & Thakur, A. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12020102 · Cited by 584 · see citing works

Clinical advances and ongoing trials of mRNA vaccines for cancer treatment

Lorentzen, C. L., Haanen, J. B. A. G., Met, Ö., & Svane, I. M. (2022) · The Lancet Oncology · doi:10.1016/s1470-2045(22)00372-2 · Cited by 540 · see citing works

Algorithm for optimized mRNA design improves stability and immunogenicity

Zhang, H., Zhang, L., Lin, A., Xu, C., Li, Z., Liu, K., Liu, B., Ma, X., Zhao, F., Jiang, H., et al. (2023) · Nature · doi:10.1038/s41586-023-06127-z · Cited by 498 · see citing works

A Comparison of Plasmid DNA and mRNA as Vaccine Technologies

Liu, M. A. (2019) · Vaccines · doi:10.3390/vaccines7020037 · Cited by 428 · see citing works

Nucleic acid delivery for therapeutic applications

Gupta, A., Andresen, J. L., Manan, R. S., & Langer, R. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113834 · Cited by 339 · see citing works

Non-viral vectors for RNA delivery

Yan, Y., Liu, X.-Y., Lu, A., Wang, X.-Y., Jiang, L.-X., & Wang, J.-C. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.01.008 · Cited by 332 · see citing works

Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy

Guevara, M. L., Persano, F., & Persano, S. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.589959 · Cited by 257 · see citing works

Formulation and Delivery Technologies for mRNA Vaccines

Zeng, C., Zhang, C., Walker, P. G., & Dong, Y. (2020) · Current topics in microbiology and immunology · doi:10.1007/82_2020_217 · Cited by 221 · see citing works

Non-viral COVID-19 vaccine delivery systems

Park, K. S., Sun, X., Aikins, M. E., & Moon, J. J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.008 · Cited by 211 · see citing works

Biomaterials for vaccine-based cancer immunotherapy

Zhang, R., Billingsley, M. M., & Mitchell, M. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.008 · Cited by 201 · see citing works

Poly(beta-amino ester)s as gene delivery vehicles: challenges and opportunities

Karlsson, J. E., Rhodes, K. R., Green, J. J., & Tzeng, S. Y. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1796628 · Cited by 192 · see citing works

Poly(lactic acid) nanoparticles and cell-penetrating peptide potentiate mRNA-based vaccine expression in dendritic cells triggering their activation

Coolen, A.-L., Lacroix, C., Mercier‐Gouy, P., Delaune, E. A., Monge, C., Exposito, J., & Verrier, B. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.12.019 · Cited by 192 · see citing works

Chemical Strategies to Boost Cancer Vaccines

Li, W., & Li, Y. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00833 · Cited by 174 · see citing works

Recent Advances in Lipid Nanoparticles for Delivery of mRNA

Yang, L., Gong, L., Wang, P., Zhao, X., Zhao, F. H., Zhang, Z., Li, Y., & Huang, W. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14122682 · Cited by 178 · see citing works

Intranasal delivery of cationic liposome-protamine complex mRNA vaccine elicits effective anti-tumor immunity

Mai, Y., Guo, J., Zhao, Y., Ma, S., Hou, Y., & Yang, J. (2020) · Cellular Immunology · doi:10.1016/j.cellimm.2020.104143 · Cited by 163 · see citing works

Immune Responses Induced by mRNA Vaccination in Mice, Monkeys and Humans

Cagigi, A., & Loré, K. (2021) · Vaccines · doi:10.3390/vaccines9010061 · Cited by 153 · see citing works

The use of RNA-based treatments in the field of cancer immunotherapy

Chehelgerdi, M., & Chehelgerdi, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01807-w · Cited by 146 · see citing works

Nanomedicine-Based Approaches for mRNA Delivery

Uchida, S., Perche, F., Pichon, C., & Cabral, H. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00618 · Cited by 139 · see citing works

A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity

Yang, R., Deng, Y., Huang, B., Huang, L., Lin, A., Li, Y., Wang, W., Liu, J., Lu, S., Zhan, Z., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00634-z · Cited by 130 · see citing works

Nanoplatforms for mRNA Therapeutics

Meng, C., Chen, Z., Li, G., Welte, T., & Shen, H. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000099 · Cited by 130 · see citing works

The roles of polymers in mRNA delivery

Huang, P., Deng, H., Zhou, Y., & Chen, X. S. (2022) · Matter · doi:10.1016/j.matt.2022.03.006 · Cited by 129 · see citing works

From structural design to delivery: mRNA therapeutics for cancer immunotherapy

Zhou, F., Huang, L., Li, S., Yang, W., Chen, F., Cai, Z., Liu, X., Xu, W., Lehto, V., Lächelt, U., et al. (2023) · Exploration · doi:10.1002/exp.20210146 · Cited by 115 · see citing works

mRNA vaccines for COVID-19 and diverse diseases

Hussain, A., Yang, H., Zhang, M., Liu, Q., Alotaibi, G., Irfan, M. F., He, H., Chang, J. K., Liang, X., Weng, Y., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.03.032 · Cited by 117 · see citing works

mRNA delivery systems for cancer immunotherapy: Lipid nanoparticles and beyond

Sentí, M. E., del Valle, L. G., & Schiffelers, R. M. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115190 · Cited by 116 · see citing works

Poly(β-amino ester)-based gene delivery systems: From discovery to therapeutic applications

Cordeiro, R. A., Serra, A. C., Coelho, J. F. J., & Faneca, H. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.024 · Cited by 106 · see citing works

mRNA-Based Cancer Vaccines: A Therapeutic Strategy for the Treatment of Melanoma Patients

Bidram, M., Zhao, Y., Shebardina, N. G., Baldin, A. V., Bazhin, A. V., Ganjalikhany, M. R., Zamyatnin, A. A., & Ganjalıkhani-Hakemi, M. (2021) · Vaccines · doi:10.3390/vaccines9101060 · Cited by 106 · see citing works

Recent developments of RNA-based vaccines in cancer immunotherapy

Faghfuri, E., Pourfarzi, F., Faghfouri, A. H., Shadbad, M. A., Hajiasgharzadeh, K., & Baradaran, B. (2020) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2020.1815704 · Cited by 99 · see citing works

Recent progress of graphene oxide as a potential vaccine carrier and adjuvant

Cao, W., He, L., Cao, W., Huang, X., Jia, K., & Dai, J. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.06.009 · Cited by 95 · see citing works

mRNA Polyplexes with Post-Conjugated GALA Peptides Efficiently Target, Transfect, and Activate Antigen Presenting Cells

Lou, B., Koker, S. D., Lau, C. Y. J., Hennink, W. E., & Mastrobattista, E. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00524 · Cited by 91 · see citing works

Adjuvant physiochemistry and advanced nanotechnology for vaccine development

Ren, H., Jia, W., Xie, Y., Yu, M., & Chen, Y. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00848c · Cited by 88 · see citing works

Cell-Penetrating Peptides: Emerging Tools for mRNA Delivery

Yokoo, H., Oba, M., & Uchida, S. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics14010078 · Cited by 86 · see citing works

Room temperature synthesis of dendritic mesoporous silica nanoparticles with small sizes and enhanced mRNA delivery performance

Wang, Y., Song, H., Yu, M., Xu, C., Liu, Y., Tang, J., Yang, Y., & Yu, C. (2018) · Journal of Materials Chemistry B · doi:10.1039/c8tb00544c · Cited by 85 · see citing works

Eliciting antitumor immunity via therapeutic cancer vaccines

Peng, K., Zhao, X., Fu, Y., & Liang, Y. (2025) · Cellular and Molecular Immunology · doi:10.1038/s41423-025-01316-4 · Cited by 89 · see citing works

Non-viral nano-immunotherapeutics targeting tumor microenvironmental immune cells

Yong, S., Chung, J. Y., Song, Y., Kim, J., Ra, S., & Kim, Y. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119401 · Cited by 79 · see citing works

Nanoparticles as Adjuvants and Nanodelivery Systems for mRNA-Based Vaccines

Alfagih, I. M., Aldosari, B. N., AlQuadeib, B. T., Almurshedi, A. S., & Alfagih, M. M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics13010045 · Cited by 79 · see citing works

Advances in the polymeric delivery of nucleic acid vaccines

Chen, G., Zhao, B., Ruiz, E. F., & Zhang, F. (2022) · Theranostics · doi:10.7150/thno.70853 · Cited by 75 · see citing works

Recent advances in applying nanotechnologies for cancer immunotherapy

Mahjub, R., Jatana, S., Lee, S. E., Qin, Z., Pauli, G., Soleimani, M., Madadi, S., & Li, S. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.010 · Cited by 74 · see citing works

Harnessing Innate Immunity Using Biomaterials for Cancer Immunotherapy

Lee, D., Huntoon, K. M., Wang, Y., Jiang, W., & Kim, B. Y. S. (2021) · Advanced Materials · doi:10.1002/adma.202007576 · Cited by 73 · see citing works

mRNA vaccines: Past, present, future

Karam, M., & Daoud, G. (2022) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2022.05.003 · Cited by 74 · see citing works

Nanomaterials for mRNA ‐based therapeutics: Challenges and opportunities

Li, D., Liu, Q., Yang, M., Xu, H., Zhu, M., Zhang, Y., Xu, J., Tian, C., Yao, J., Wang, L., et al. (2023) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10492 · Cited by 71 · see citing works

Nanotechnology‐Assisted RNA Delivery: From Nucleic Acid Therapeutics to COVID‐19 Vaccines

Rinoldi, C., Zargarian, S. S., Nakielski, P., Li, X., Liguori, A., Petronella, F., Presutti, D., Wang, Q., Costantini, M., Sio, L. D., et al. (2021) · Small Methods · doi:10.1002/smtd.202100402 · Cited by 73 · see citing works

Recent advances in mRNA vaccine delivery

Tan, L., & Sun, X. (2018) · Nano Research · doi:10.1007/s12274-018-2091-z · Cited by 70 · see citing works

Lipid‐based nanoparticles as drug delivery systems for cancer immunotherapy

Hao, Y., Ji, Z., Zhou, H., Wu, D., Gu, Z., Wang, D., & ten Dijke, P. (2023) · MedComm · doi:10.1002/mco2.339 · Cited by 66 · see citing works

At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids

Uludağ, H., Ubeda, A., & Ansari, A. S. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00131 · Cited by 66 · see citing works

Serum Nuclease Susceptibility of mRNA Cargo in Condensed Polyplexes

Yen, A., Cheng, Y., Sylvestre, M., Gustafson, H. H., Puri, S., & Pun, S. H. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00134 · Cited by 67 · see citing works

Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity

Fan, T., Xu, C., Wu, J., Cai, Y., Cao, W., Shen, H., Zhang, M., Zhu, H., Yang, J., Zhu, Z., et al. (2024) · Science Advances · doi:10.1126/sciadv.adn9961 · Cited by 61 · see citing works

Optimization of the Linker Length of Mannose-Cholesterol Conjugates for Enhanced mRNA Delivery to Dendritic Cells by Liposomes

Wang, F., Xiao, W., Elbahnasawy, M. A., Bao, X., Zheng, Q., Gong, L., Zhou, Y., Yang, S., Fang, A., Farag, M. M. S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00980 · Cited by 60 · see citing works

Toll-like receptor-targeted anti-tumor therapies: Advances and challenges

Yang, Y., Li, H., Fotopoulou, C., Cunnea, P., & Zhao, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049340 · Cited by 60 · see citing works

Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

Guevara, M. L., Jilesen, Z., Stojdl, D., & Persano, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b00489 · Cited by 58 · see citing works

Development and applications of mRNA treatment based on lipid nanoparticles

Wang, Z., Ma, W., Fu, X., Qi, Y., Zhao, Y., & Zhang, S. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108130 · Cited by 57 · see citing works

Local and systemic delivery of mRNA encoding survivin-T34A by lipoplex for efficient colon cancer gene therapy

Zhang, X., Men, K., Zhang, Y., Zhang, R., Yang, L., & Duan, X. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s198747 · Cited by 57 · see citing works

Poly(β-amino ester)s-based nanovehicles: Structural regulation and gene delivery

Zhang, J., Cai, X., Dou, R., Guo, C., Tang, J., Hu, Y., Chen, H.-Q., & Chen, J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.019 · Cited by 56 · see citing works

Lipid-Based Vectors for Therapeutic mRNA-Based Anti-Cancer Vaccines

Guevara, M. L., Persano, S., & Persano, F. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190619150221 · Cited by 56 · see citing works

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine

Perche, F., Clemençon, R., Schulze, K., Ebensen, T., Guzmán, C. A., & Pichon, C. (2019) · Molecular Therapy - Nucleic Acids · doi:10.1016/j.omtn.2019.07.014 · Cited by 55 · see citing works

Establishing Preferred Product Characterization for the Evaluation of RNA Vaccine Antigens

Poveda, C., Biter, A. B., Bottazzi, M. E., & Strych, U. (2019) · Vaccines · doi:10.3390/vaccines7040131 · Cited by 54 · see citing works

Recent advancements in lipid–mRNA nanoparticles as a treatment option for cancer immunotherapy

Karmacharya, P., Patil, B. R., & Kim, J. O. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00569-9 · Cited by 54 · see citing works

Targeting strategies for mRNA delivery

Meyer, R. A., Neshat, S. Y., Green, J. J., Santos, J. L., & Tuesca, A. D. (2022) · Materials Today Advances · doi:10.1016/j.mtadv.2022.100240 · Cited by 53 · see citing works

Edible and cation-free kiwi fruit derived vesicles mediated EGFR-targeted siRNA delivery to inhibit multidrug resistant lung cancer

Huang, H., Yi, X., Wei, Q., Li, M., Cai, X., Lv, Y., Weng, L., Mao, Y., Fan, W., Zhao, M., et al. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-01766-w · Cited by 53 · see citing works

Advances in mRNA therapeutics for cancer immunotherapy: From modification to delivery

Han, G., Noh, D., Lee, H., Lee, S., Kim, S., Yoon, H. Y., & Hyeon, L. S. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114973 · Cited by 52 · see citing works

Emerging Concepts of Nanobiotechnology in mRNA Delivery

Wang, Y., & Yu, C. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.202003545 · Cited by 52 · see citing works

High‐Precision Synthesis of RNA‐Loaded Lipid Nanoparticles for Biomedical Applications

Seo, H., Jeon, L., Kwon, J., & Lee, H. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202203033 · Cited by 51 · see citing works

mRNA vaccines in the prevention and treatment of diseases

Gu, Y., Duan, J., Yang, N., Yang, Y., & Zhao, X. (2022) · MedComm · doi:10.1002/mco2.167 · Cited by 51 · see citing works

Scaffold-mediated delivery for non-viral mRNA vaccines

Chen, R., Zhang, H., Yan, J., & Bryers, J. D. (2018) · Gene Therapy · doi:10.1038/s41434-018-0040-9 · Cited by 50 · see citing works

Advances in the design and delivery of RNA vaccines for infectious diseases

Lokras, A. G., Bobak, T. R., Baghel, S. S., Sebastiani, F., & Foged, C. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115419 · Cited by 50 · see citing works

mRNA delivery in cancer immunotherapy

Zhong, Y., Du, S., & Dong, Y. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.03.001 · Cited by 48 · see citing works

Lipid Nanoparticle-Based Delivery SystemA Competing Place for mRNA Vaccines

Zhang, X., Li, Y., & Zhou, Z. (2024) · ACS Omega · doi:10.1021/acsomega.3c08353 · Cited by 43 · see citing works

Immunostimulation and Immunosuppression: Nanotechnology on the Brink

Fontana, F., Figueiredo, P., Bauleth‐Ramos, T., Correia, A., & Santos, H. A. (2018) · Small Methods · doi:10.1002/smtd.201700347 · Cited by 41 · see citing works

An mRNA vaccine elicits STING-dependent antitumor immune responses

Chen, Z., Meng, C., Mai, J., Liu, Y., Li, H., & Shen, H. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.11.013 · Cited by 40 · see citing works

Survival strategies of cancer cells: the role of macropinocytosis in nutrient acquisition, metabolic reprogramming, and therapeutic targeting

Xu, G., Zhang, Q., Cheng, R., Qu, J., & Li, W. (2025) · Autophagy · doi:10.1080/15548627.2025.2452149 · Cited by 38 · see citing works

Enhancing cancer immunotherapy through nanotechnology-mediated tumor infiltration and activation of immune cells

Shen, H., Sun, T., Hoang, H. H., Burchfield, J. S., Hamilton, G. F., Mittendorf, E. A., & Mauro Ferrari, B. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.09.002 · Cited by 37 · see citing works

Non-Viral Carriers for Nucleic Acids Delivery: Fundamentals and Current Applications

Shtykalova, S., Deviatkin, D., Freund, S., Egorova, A., & Kiselev, A. (2023) · Life · doi:10.3390/life13040903 · Cited by 37 · see citing works

Nanoliposomes as safe and efficient drug delivery nanovesicles

Fatfat, Z., Karam, M., Maatouk, B. I., Fahs, D., & Gali‐Muhtasib, H. U. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91668-4.00002-2 · Cited by 33 · see citing works

Emerging advances in delivery systems for mRNA cancer vaccines

Jiang, Z., Xu, Y., Du, G., & Sun, X. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.04.039 · Cited by 34 · see citing works

Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination

Zhang, W., Liu, Y., Chin, J. M., & Phua, K. K. L. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.03.011 · Cited by 33 · see citing works

Transcutaneous delivery of DNA/mRNA for cancer therapeutic vaccination

Sun, X., Zeng, L., & Huang, Y. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3089 · Cited by 32 · see citing works

Single Micelle Vectors based on Lipid/Block Copolymer Compositions as mRNA Formulations for Efficient Cancer Immunogene Therapy

Li, J., Men, K., Gao, Y., Wu, J., Lei, S., Yang, Y., & Pan, H. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.1c00461 · Cited by 30 · see citing works

Lipid- and Polymer-Based Nanocarrier Platforms for Cancer Vaccine Delivery

Sunoqrot, S., Gaber, S. A. A., Abujaber, R., Al-Majawleh, M., & Talhouni, S. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00843 · Cited by 30 · see citing works

Nucleic acid-loaded poly(beta-aminoester) nanoparticles for cancer nano-immuno therapeutics: the good, the bad, and the future

Magaña, J. R., Guerra‐Rebollo, M., Borrós, S., & Fornaguera, C. (2024) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01585-y · Cited by 29 · see citing works

Emerging Advances in Cationic Liposomal Cancer Nanovaccines: Opportunities and Challenges

Ahmad, M. Z., Ahmad, J., Alasmary, M. Y., Abdel‐Wahab, B. A., Warsi, M. H., Haque, A., & Chaubey, P. (2021) · Immunotherapy · doi:10.2217/imt-2020-0258 · Cited by 29 · see citing works

A single immunization with core–shell structured lipopolyplex mRNA vaccine against rabies induces potent humoral immunity in mice and dogs

Wan, J., Yang, J., Wang, Z., Shen, R., Zhang, C., Wu, Y., Zhou, M., Chen, H., Fu, Z. F., Sun, H., et al. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2270081 · Cited by 29 · see citing works

Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines

Lin, F., Lin, E. Z., Anekoji, M., Ichim, T. E., Hu, J. K., Marincola, F. M., Jones, L. D., Kesari, S., & Ashili, S. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04724-0 · Cited by 28 · see citing works

Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications

Tang, T., Weng, T., Jia, H., Luo, S., Xu, Y., Li, L., & Zhang, P. (2019) · Biomaterials Science · doi:10.1039/c8bm01219a · Cited by 28 · see citing works

Poly (beta‐amino ester) as an in vivo nanocarrier for therapeutic nucleic acids

Nezhad, M. S. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28269 · Cited by 28 · see citing works

Nanoparticles overcome adaptive immune resistance and enhance immunotherapy via targeting tumor microenvironment in lung cancer

Zhang, X., Wang, X., Hou, L., Xu, Z. Q., Liu, Y., & Wang, X. S. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1130937 · Cited by 28 · see citing works

Carboxymethylated Alginate-Resiquimod Micelles Reverse the Immunosuppressive Tumor Microenvironment and Synergistically Enhance the Chemotherapy and Immunotherapy for Gastric Cancer

Chen, J., Liu, X., Zhao, S., Chen, H., Lu, T., Wang, J., Han, J., Wu, W., Shen, X., & Li, C. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c06828 · Cited by 28 · see citing works

Advances in Nonviral mRNA Delivery Materials and Their Application as Vaccines for Melanoma Therapy

Neill, B., Romero, A. R., & Fenton, O. S. (2023) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c00721 · Cited by 30 · see citing works

Advances in mRNA vaccines

Li, M., Wang, Z., Xie, C., & Xia, X. (2022) · International review of cytology · doi:10.1016/bs.ircmb.2022.04.011 · Cited by 30 · see citing works

Non‐viral gene delivery for cancer immunotherapy

Wang, W., Saeed, M., Zhou, Y., Yang, L., Wang, D., & Yu, H. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3092 · Cited by 27 · see citing works

Advancing mRNA technologies for therapies and vaccines: An African context

Kairuz, D., Samudh, N., Ely, A., Arbuthnot, P., & Bloom, K. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1018961 · Cited by 25 · see citing works

Nanotechnology in the arena of cancer immunotherapy

Asadujjaman, M., Cho, K. H., Jang, D.-J., Kim, J.-E., & Jee, J. (2020) · Archives of Pharmacal Research · doi:10.1007/s12272-020-01207-4 · Cited by 25 · see citing works

Advancing mRNA vaccines: A comprehensive review of design, delivery, and efficacy in infectious diseases

Lu, Y., Qian, C., Huang, Y., Ren, T., Xie, W., Xia, N., & Li, S. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.145501 · Cited by 26 · see citing works

Smart CAR-T Nanosymbionts: archetypes and proto-models

Baena, J. C., Victoria, J. S., Toro-Pedroza, A., Aragón, C. C., Ortiz‐Guzman, J., García-Robledo, J. E., Torres, D., Ríos-Serna, L. J., Albornóz, L. L., Rosales, J. D., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635159 · Cited by 25 · see citing works

In the Era of mRNA Vaccines, Is There Any Hope for HIV Functional Cure?

Esteban, I., Pastor-Quiñones, C., Usero, L., Plana, M., García, F., & Leal, L. (2021) · Viruses · doi:10.3390/v13030501 · Cited by 26 · see citing works

Biomaterials for polynucleotide delivery to anchorage-independent cells

Ansari, A. S., Santerre, P., & Uludağ, H. (2017) · Journal of Materials Chemistry B · doi:10.1039/c7tb01833a · Cited by 24 · see citing works

Biomimetic functionalized metal organic frameworks as multifunctional agents: Paving the way for cancer vaccine advances

Tousian, B., Khosravi, A., Ghasemi, M. H., & Kadkhodaie, M. (2024) · Materials Today Bio · doi:10.1016/j.mtbio.2024.101134 · Cited by 23 · see citing works

Abstract LB-205: A lipoplex-based mRNA nanovaccine for cancer immunotherapy

Hongxia, Z., You, X., Xiaojuan, W., Wang, Z., Xu, F., Wu, J., & Xia, X. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-lb-205 · Cited by 6 · see citing works

A Structurally Stabilized Lipopolymer Nanoplatform Targeting Pan‐Tissue Antigen‐Presenting Cells Enables Durable in situ mRNA Cancer Immunotherapy

Zeng, L. L., Shen, Q., Wei, L., Jiang, M. J., Liao, J., Ren, Y., Zhang, Z., Fan, H., Cao, X., Chen, J., et al. (2026) · Advanced Materials · doi:10.1002/adma.202520594 · Cited by 3 · see citing works

Codelivery of mRNA with α-Galactosylceramide Using a New Lipopolyplex Formulation Induces a Strong Antitumor Response upon Intravenous Administration

Guevara, M. L., Jilesen, Z., Stojdl, D., & Persano, S. (2019) · ACS Omega · doi:10.1021/acsomega.9b00489 · Cited by 58 · see citing works

Preclinical evaluation of mRNA trimannosylated lipopolyplexes as therapeutic cancer vaccines targeting dendritic cells

Moignic, A. L., Malard, V., Benvegnu, T. J., Lemiègre, L., Berchel, M., Jaffrès, P., Baillou, C., Guillot‐Delost, M., Macedo, R., Rochefort, J., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.035 · Cited by 127 · see citing works

Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety

Van der Jeught, K., De Koker, S., Bialkowski, L., Heirman, C., Tjok Joe, P., Perche, F., Maenhout, S., Bevers, S., Broos, K., Deswarte, K., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b00966 · Cited by 139 · see citing works